日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells

IL-15 超激动剂 N-803 可增强 CD34+ 祖细胞衍生 NK 细胞的 IFNγ 产生并杀伤白血病和卵巢癌细胞。

期刊:Cancer Immunology Immunotherapy
影响因子:8.1
doi:10.1007/s00262-020-02749-8
J M R Van der Meer ，R J A Maas # ，K Guldevall # ，K Klarenaar ，P K J D de Jonge ，J S Hoogstad-van Evert ，A B van der Waart ，J Cany ，J T Safrit ，J H Lee ，E Wagena ，P Friedl ，B Önfelt ，L F Massuger ，N P M Schaap ，J H Jansen ，W Hobo ，H Dolstra
肿瘤免疫
IFNγ
NK 细胞
白血病
细胞生物学
肿瘤
CD34
卵巢癌
IL-15
CD3
发表日期：2021
文献求助 收藏

Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells

更正：IL-15 超激动剂 N-803 可增强 CD34+ 祖细胞衍生 NK 细胞的 IFNγ 产生并杀伤白血病和卵巢癌细胞

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-021-03049-5
Van der Meer, J M R; Maas, R J A; Guldevall, K; Klarenaar, K; De Jonge, P K J D; Hoogstad-van Evert, J S; van der Waart, A B; Cany, J; Safrit, J T; Lee, J H; Wagena, E; Friedl, P; Önfelt, B; Massuger, L F; Schaap, N P M; Jansen, J H; Hobo, W; Dolstra, H
肿瘤
肿瘤免疫
IFNγ
卵巢癌
白血病
CD3
CD34
细胞生物学
NK 细胞
IL-15
发表日期：2021
文献求助 收藏

Cognitive Impairment in Older Cancer Patients Treated with First-Line Chemotherapy

接受一线化疗的老年癌症患者的认知障碍

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers13246171
Dos Santos, Mélanie; Licaj, Idlir; Bellera, Carine; Cany, Laurent; Binarelli, Giulia; Soubeyran, Pierre; Joly, Florence
肿瘤
肿瘤免疫
神经科学
发表日期：2021
文献求助 收藏

TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer

TIGIT 阻断可增强卵巢癌中腹膜 NK 细胞的功能，并改变 DNAM-1/TIGIT/CD96 检查点分子的表达

期刊:Oncoimmunology
影响因子:
doi:10.1080/2162402X.2020.1843247
Ralph Ja Maas, Janneke S Hoogstad-van Evert, Jolien Mr Van der Meer, Vera Mekers, Somayeh Rezaeifard, Alan J Korman, Paul Kjd de Jonge, Jeannette Cany, Rob Woestenenk, Nicolaas Pm Schaap, Leon F Massuger, Joop H Jansen, Willemijn Hobo, Harry Dolstra
信号转导
免疫
细胞生物学
肿瘤
卵巢癌
自然杀伤细胞
FlowCytometry
Checkpoint
Human
IFNGR
IGG1
发表日期：2020
文献求助 收藏

Systemic chemotherapy plus cetuximab after complete surgery in the treatment of isolated colorectal peritoneal carcinoma: COCHISE phase II clinical trial

孤立性结直肠腹膜癌根治术后行全身化疗联合西妥昔单抗治疗：COCHISE II期临床试验

期刊:BMC Research Notes
影响因子:1.7
doi:10.1186/s13104-019-4476-9
Evrard, Serge; Desolneux, Grégoire; Bellera, Carine; Esnaud, Thomas; Bécouarn, Yves; Collet, Denis; Chafai, Najim; Marchal, Francois; Cany, Laurent; Lermite, Emilie; Rivoire, Michel; Mathoulin-Pélissier, Simone
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients

腹腔NK细胞对IL-15有反应，其百分比与晚期卵巢癌患者的预后相关。

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.26199
Hoogstad-van Evert, Janneke S; Maas, Ralph J; van der Meer, Jolien; Cany, Jeannette; van der Steen, Sophieke; Jansen, Joop H; Miller, Jeffrey S; Bekkers, Ruud; Hobo, Willemijn; Massuger, Leon; Dolstra, Harry
肿瘤
肿瘤免疫
卵巢癌
细胞生物学
IL-15
发表日期：2018
文献求助 收藏

Umbilical cord blood CD34+ progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rgnull mice

脐带血 CD34+ 祖细胞衍生的 NK 细胞可有效杀死 NOD/SCID/IL2Rgnull 小鼠中的卵巢癌球体和腹膜内肿瘤

期刊:Oncoimmunology
影响因子:
doi:10.1080/2162402X.2017.1320630
Janneke S Hoogstad-van Evert, Jeannette Cany, Dirk van den Brand, Manon Oudenampsen, Roland Brock, Ruurd Torensma, Ruud L Bekkers, Joop H Jansen, Leon F Massuger, Harry Dolstra
肿瘤
卵巢癌
自然杀伤细胞
发表日期：2017
文献求助 收藏

Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial

针对接受化疗且有营养不良风险的老年患者的营养建议：一项为期两年的随机对照试验

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0108687
Bourdel-Marchasson, Isabelle; Blanc-Bisson, Christelle; Doussau, Adélaïde; Germain, Christine; Blanc, Jean-Frédéric; Dauba, Jérôme; Lahmar, Cyril; Terrebonne, Eric; Lecaille, Cédric; Ceccaldi, Joël; Cany, Laurent; Lavau-Denes, Sandrine; Houede, Nadine; Chomy, François; Durrieu, Jessica; Soubeyran, Pierre; Senesse, Pierre; Chene, Geneviève; Fonck, Mariane
发表日期：2014
文献求助 收藏

FOLFIRI® and bevacizumab in first-line treatment for colorectal cancer patients: safety, efficacy and genetic polymorphisms

FOLFIRI®联合贝伐单抗一线治疗结直肠癌患者：安全性、有效性和遗传多态性

期刊:BMC Research Notes
影响因子:1.7
doi:10.1186/1756-0500-7-260
Bécouarn, Yves; Cany, Laurent; Pulido, Marina; Beyssac, Richard; Texereau, Patrick; Le Morvan, Valérie; Béchade, Dominique; Brunet, René; Aitouferoukh, Sofiane; Lalet, Caroline; Mathoulin-Pélissier, Simone; Fonck, Marianne; Robert, Jacques
肿瘤
肠癌
肿瘤免疫
发表日期：2014
文献求助 收藏

Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia

多药耐药蛋白4/ATP结合盒转运体4：急性髓系白血病的潜在治疗新靶点

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.2425
Sabrina Copsel, Ariana Bruzzone, Maria May, Julien Beyrath, Victoria Wargon, Jeannette Cany, Frans G M Russel, Carina Shayo, Carlos Davio
肿瘤
白血病
发表日期：2014
文献求助 收藏